what are the brand names for tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Eli Lilly's weight loss, diabetes

Longevity Focus: Maintaining low-grade receptor activation for cardiovascular protection without rapid weight loss

For people with chronic pancreatitis, the decision becomes more complex

Protein Recommendations for Weight Loss in Elite Athletes

Most viral sore throats, meanwhile, clear on their own within about a week

Lillys tirzepatide (sold as Mounjaro and Zepbound) will not only surpass Ozempic and Wegovy in total revenue, it will also become the top-selling drug in the world by new sales contribution in 2026

The FDA itself released an alert in July 2025 warning of serious risk from compounded GLP-1s such as examples where overdoses occurred with patients receiving multiple times intended dose due to dosing errors